Stocktoria
Tarsus Pharmaceuticals, Inc. TARS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-10-16
Tarsus Pharmaceuticals, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 3,266,714 | $88.8M |
| D. E. Shaw & Co., Inc. | 791,146 | $55.5M |
| MILLENNIUM MANAGEMENT LLC | 594,579 | $41.7M |
| Point72 Asset Management, L.P. | 226,251 | $15.9M |
| CITADEL ADVISORS LLC | 183,097 | $12.8M |
| RENAISSANCE TECHNOLOGIES LLC | 73,400 | $5.1M |
| AQR CAPITAL MANAGEMENT LLC | 30,453 | $2.1M |
| TWO SIGMA INVESTMENTS, LP | 19,078 | $1.3M |
Source: SEC EDGAR filings · CIK 0001819790 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.